Avenue Capital Group, established in 1995 by Marc Lasry and Sonia E. Gardner, is a New York City-based investment firm specializing in distressed debt and special situation investments across the United States, Europe, and Asia. The firm is recognized for its expertise in investing in the public and private debt and equity securities of distressed companies across various industries, as well as its focus on the real estate sector and securitized loan obligations. Avenue Capital Group provides a range of debt facilities, including loans, revolving credit lines, second lien, secured debt, mezzanine financing, senior debt, and bonds, catering to small and medium-sized companies for purposes such as bankruptcy, buyouts, initial public offerings, and growth initiatives. With a workforce of approximately 300 employees, Avenue Capital leverages the extensive experience of its founders, who have dedicated their careers to distressed investments.
Spectral AI, Inc. is a predictive analytics company focused on advancing wound care through its proprietary AI algorithms and optical technology. The company has developed the DeepView® Wound Imaging Solution, a multispectral imaging system that has received FDA Breakthrough Designation for burn indications. This innovative technology enables the differentiation between non-healing and healing human tissue that is not visible to the naked eye. By providing 'Day One' healing assessments for burn wounds and diabetic foot ulcers, Spectral AI aims to assist clinicians in making more accurate and timely treatment decisions, ultimately enhancing patient care in the wound care sector.
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
CalciMedica, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, specializing in the discovery and development of small molecule drugs aimed at treating autoimmune and inflammatory diseases. Founded in December 2006 by a team of scientists with backgrounds in the field, the company focuses on the specific inhibition of calcium release-activated calcium channels. This proprietary technology is designed to modulate the immune response and protect against tissue cell injury, addressing significant unmet medical needs in life-threatening inflammatory conditions. CalciMedica's innovative approach aims to offer therapeutic benefits for diseases that currently lack approved treatment options.
Mercury/13 is a multi-club ownership group focused on acquiring equity interests in European professional women's football teams. The company aims to become the industry standard in women's football ownership by identifying and investing in the next decade's super clubs and fueling their commercial power to attract a massive yet underserved market: women.
Unrivaled is a professional women's basketball league that focuses on creating competitive opportunities for female athletes. The league offers an innovative platform that serves as a viable alternative for women players seeking competition and income during the off-season of the WNBA. By organizing three versus three matches, Unrivaled aims to enhance the visibility of women's basketball while providing an engaging format for both players and fans.
Epica International, Inc. specializes in designing, developing, and distributing advanced robotic systems aimed at enhancing precision and outcomes in various medical fields. The company's product lineup includes Vimago, a CT imaging and fluoroscopy device for veterinary diagnostics; Pegaso, a high-definition CT system for equine veterinary applications; and Artemis, a device for non-invasive regenerative therapy in animals. Additionally, Epica offers Ortis, a carving robotic system for orthopedic applications, and SandRob, a surface processing system for detailed finishing needs. Their ScultoRob system is designed for milling artistic and architectural designs, while ARPP serves as a robotic simulation software for control and programming. Founded in 2013 and based in San Clemente, California, Epica International aims to integrate precision robotics with imaging technologies to improve diagnostic and therapeutic capabilities in veterinary medicine, orthotics, and surface processing markets.
CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
PolarityTE, Inc. is a clinical-stage biotechnology company specializing in regenerative medicine and the development of innovative tissue products and biomaterials. Based in Salt Lake City, Utah, the company focuses on creating functionally polarized human tissues to enhance clinical outcomes and support biomedical research. Its flagship product, SkinTE, utilizes a patient's own tissue to facilitate the regeneration of skin for individuals with acute and chronic wounds, burns, and other skin-related conditions. By employing a method that promotes the natural healing process, PolarityTE aims to transform tissue engineering through its technology platform, which simplifies the regeneration of various cells and tissues. Founded in 2015, the company is dedicated to improving patient care and outcomes by leveraging the body's innate healing capabilities.
ProducePay, founded by Pablo Borquez Schwarzbeck, aims to revolutionize the global fresh produce supply chain by addressing the challenges of economic and food waste. This AgTech company has developed a Predictable Commerce Platform that enhances the connection between growers and buyers, offering access to capital, trading opportunities, insights, and improved supply chain visibility. By providing farmers with immediate liquidity and financing options, along with real-time pricing data, ProducePay enables them to make informed decisions and expand their businesses. This platform not only facilitates efficient transactions but also ensures that consumers receive fresher produce while promoting sustainable practices within the agricultural industry.
ITS Technology Group Limited is a provider of internet, IT managed services, and telephony solutions aimed at rural and urban businesses, communities, and regions. Established in 2013 and based in Chester, UK, the company specializes in broadband services, including wireless WAN and full fiber solutions such as fiber to the premise and leased lines. Additionally, it offers telecommunications services encompassing business lines, VoIP options, and managed IT services that cover Microsoft Office 365, cloud storage, and network infrastructure. ITS Technology Group focuses on serving both private and public sector organizations, facilitating access to high-speed connectivity and cost-effective technology solutions. The company operates through various offices in Cleveland, Glasgow, West Yorkshire, and Powys, and collaborates with wholesale and technology partners to enhance service delivery.
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company based in Garden City, New York. It focuses on developing inhaled nitric oxide (NO) for the treatment of respiratory conditions and gaseous NO for addressing solid tumors. The company's primary innovation is the LungFit system, a generator and delivery system designed to produce nitric oxide from ambient air. This system is currently undergoing clinical trials for various conditions, including lung infections, persistent pulmonary hypertension in newborns, and severe acute respiratory syndrome coronavirus 2. The LungFit system offers the ability to deliver nitric oxide continuously or intermittently, tailored to patient needs, and aims to eliminate the reliance on traditional gas cylinders in hospital settings. Beyond Air was founded in 2011 and has a strong emphasis on improving patient outcomes through its advanced nitric oxide formulations.
Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company based in New York, focused on developing innovative microdose therapeutics through its proprietary piezo-print delivery technology known as the Optejet. The company's aim is to enhance the delivery of ophthalmic pharmaceuticals by replacing traditional eye dropper methods, thereby improving safety, tolerability, and patient compliance for various eye treatments. Eyenovia's product pipeline includes several candidates: MicroLine, currently in Phase III development for presbyopia; MicroProst, also in Phase III trials for chronic angle closure glaucoma and ocular hypertension; MicroStat, which has completed Phase III trials for mydriasis; MicroTears for red eye and itch relief; and MicroPine for progressive myopia. The company seeks to address indications that lack FDA-approved drug therapies and was established in 2014, originally as PGP Holdings V, Inc., before rebranding to Eyenovia.
Kin Insurance, Inc. is a digital insurance agency specializing in homeowners insurance and related products, including mobile home, condo, flood, manufactured home, landlord, umbrella, hurricane, wildfire, and second home insurance. Founded in 2016 and headquartered in Chicago, Illinois, with an additional office in St. Petersburg, Florida, Kin Insurance operates payment processing offices in Palatine and Chicago. By eliminating external agents, Kin Insurance offers a direct-to-consumer model that enhances the convenience and affordability of homeowners insurance. The company's technology platform provides a seamless user experience, personalized coverage options, and efficient claims processing. Kin leverages extensive property data to deliver precise pricing and improve underwriting outcomes.
Oliver Space is a home furnishing company founded in 2018 in San Francisco, California, by Chan Park. The company specializes in providing a wide range of furniture and home decor products, including sofas, rugs, pillows, and plants, through an online platform. Oliver Space offers customers flexible payment options, allowing them to either rent or purchase items on a monthly subscription basis. This model enables individuals to create aesthetically pleasing living spaces without the burden of high upfront costs. Additionally, customers can enjoy a trial period before committing to a purchase, with the option of 0% interest financing, making home decoration both easy and affordable.
Enerkem Inc. is a cleantech company based in Montreal, Canada, specializing in the production of renewable biofuels and chemicals derived from waste materials. The company utilizes a proprietary thermochemical process to convert non-recyclable municipal solid waste into cellulosic ethanol and other renewable chemicals. Over a decade of research has validated Enerkem's technology, which addresses issues related to oil dependence and waste disposal. The company operates advanced facilities that support its business model of producing biofuels profitably from a diverse range of feedstocks. Enerkem is majority-owned by a mix of institutional and clean-technology investors, including various venture capital firms and industrial investors. With a workforce of approximately 170 employees across Canada and the United States, Enerkem is committed to transforming waste into sustainable energy solutions.
Aytu Biopharma is a specialty healthcare company focused on developing products for conditions influenced by redox modulation, with a primary emphasis on urological issues, particularly male sexual dysfunction and male infertility. In addition to its urological focus, the company also has a commercial portfolio that includes prescription therapeutics for attention deficit hyperactivity disorder and other pediatric conditions. Aytu Biopharma is expanding its therapeutic development pipeline with a prospective treatment for vascular Ehlers-Danlos Syndrome, a rare genetic disorder associated with significant health risks, which has received Orphan Drug designation from the FDA. Through its diverse offerings, Aytu Biopharma aims to address various healthcare needs while seeking opportunities for growth in multiple therapeutic areas.
Intellihot specializes in the manufacture of tankless water heating systems tailored for both residential and commercial use. Founded in 2005, the company emerged from a practical need when a traditional water heater malfunctioned, leading to significant water damage. Intellihot's systems are designed to conserve space by eliminating the need for bulky storage tanks, and they incorporate advanced technology, including Wi-Fi and 3G/4G connectivity. This connectivity allows users to monitor and analyze water usage patterns, providing an efficient on-demand heating solution that optimizes performance and resource use. The innovative design of Intellihot's products has garnered recognition and includes several patents pending.
Netomnia is a fiber-to-the-premises (FTTP) broadband service provider based in London, England, established in 2019. The company focuses on constructing full-fiber broadband infrastructure and networks throughout the United Kingdom, delivering symmetrical multi-gigabit services. This approach enables both residential and business clients to access reliable internet speeds tailored to their specific requirements.
Delcath Systems, Inc. is an interventional oncology company based in New York that specializes in the treatment of primary and metastatic liver cancers. The company's primary product is Melphalan Hydrochloride for Injection, which is used in conjunction with the Delcath Hepatic Delivery System to deliver high-dose chemotherapy directly to the liver while minimizing systemic exposure and side effects. Delcath is currently conducting Phase III clinical trials, including the FOCUS Trial for patients with hepatic dominant ocular melanoma and the ALIGN Trial for intrahepatic cholangiocarcinoma. Additionally, Delcath offers Melphalan Hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System in Europe. Founded in 1988, Delcath Systems is dedicated to advancing treatment options for patients with liver cancer.
Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most promising approaches in the treatment of Cancers, HIV, Autoimmune Diseases, inflammatory conditions and other chronic infectious diseases.
Third Pole is focused on developing an innovative medical inhalation device that generates nitric oxide from air and electricity on-demand, providing a clean and tankless alternative to traditional gas delivery systems. This technology is designed to address hypoxic respiratory failure in newborns, offering a life-saving solution that is accessible and efficient. By eliminating the need for large compressed gas cylinders, Third Pole's device not only enhances the treatment of neonatal conditions but also has the potential to expand therapeutic applications to other respiratory issues, including pulmonary hypertension, interstitial lung disease, and chronic obstructive pulmonary disease. This advancement aims to improve the availability of essential therapies for patients in need.
Asset Reconstruction Company (India) Ltd. is a Mumbai-based firm specializing in asset reconstruction and management services. The company focuses on acquiring non-performing assets (NPAs) from Indian banks and financial institutions, helping them stabilize liquidity and enhance operational efficiency. Since its establishment, it has successfully resolved over Rs. 780 billion worth of NPAs, utilizing trusts and special purpose vehicles to facilitate the management of these financial assets. Through its efforts, the company plays a critical role in supporting the financial sector in India by enabling institutions to meet their financial objectives.
C.P. Crane
Acquisition in 2016
Owns and operates a coal-fired power plant near Baltimore
Ambow Education Holding Ltd. is a prominent provider of educational and career enhancement services in China, catering to students, recent graduates, and corporate employees. The company operates primarily through two segments: K-12 Schools and Career Preparation & Career Enhancement (CP&CE) Programs. The K-12 Schools segment offers a range of educational services, including K-12 programs, tutoring, and international education. The CP&CE Programs focus on tutoring services to improve academic performance and prepare students for high-stakes entrance exams, alongside providing educational software and career enhancement services aimed at improving job prospects for graduates. Additionally, the company offers professional skills training and management training for corporate clients. As of December 31, 2019, Ambow operated 60 centers and schools across China, including K-12 schools, tutoring centers, and career enhancement facilities. Founded in 2000, the company is headquartered in Beijing and employs a combination of online and offline delivery methods supported by proprietary technologies.
Wuxi Qiaolian specializes in research, design manufacture processes and sales of CNC machine tools and general-purpose machine tools, wind power equipments, and metallurgical equipments.
Ambow Education Holding Ltd. is a prominent provider of educational and career enhancement services in China, catering to students, recent graduates, and corporate employees. The company operates primarily through two segments: K-12 Schools and Career Preparation & Career Enhancement (CP&CE) Programs. The K-12 Schools segment offers a range of educational services, including K-12 programs, tutoring, and international education. The CP&CE Programs focus on tutoring services to improve academic performance and prepare students for high-stakes entrance exams, alongside providing educational software and career enhancement services aimed at improving job prospects for graduates. Additionally, the company offers professional skills training and management training for corporate clients. As of December 31, 2019, Ambow operated 60 centers and schools across China, including K-12 schools, tutoring centers, and career enhancement facilities. Founded in 2000, the company is headquartered in Beijing and employs a combination of online and offline delivery methods supported by proprietary technologies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.